Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Oral Regimens Shorten Rifampin-Resistant Tuberculosis Treatment
February 2025
New 9-month, all-oral regimens for fluoroquinolone-susceptible, rifampin-resistant tuberculosis are as effective as the standard longer-duration therapy.
Read more
22 Feb 2025
New Oral Regimens Shorten Rifampin-Resistant Tuberculosis Treatment
New 9-month, all-oral regimens for fluoroquinolone-susceptible, rifampin-resistant tuberculosis are as effective as the standard longer-duration therapy.
20 Feb 2025
STI Surge in Europe Sparks Public Health Concern
The ECDC’s Annual Epidemiological Reports analysed surveillance data from 29 EU/EEA countries, tracking trends in gonorrhoea, syphilis, and chlamydia.
18 Feb 2025
Cytokine Markers Predict Mortality in Advanced HIV Cases
Researchers have identified key immunological markers associated with mortality in hospitalised people living with HIV/AIDS.
16 Feb 2025
Faecal Microbiota Transplantation: A New Era for
C. difficile
Treatment
A new systematic review and network meta-analysis confirms that faecal microbiota transplantation is the most effective treatment for Clostridioides difficile infection.
14 Feb 2025
Carbapenem-Resistant Infections Rising Across Europe
Carbapenem-resistant Enterobacterales infections are on the rise across Europe, with experts warning of worsening transmission and increasing resistance.
13 Feb 2025
Pseudomonas Infection Triggers Lung Transplant Rejection Through Immune Disruption
Pseudomonas aeruginosa infection drives lung transplant rejection by inducing regulatory T cell death and promoting B cell responses.
12 Feb 2025
Twelve New Mpox Vaccination Sites Open Across England
The NHS has expanded its mpox vaccination programme across England, opening 12 new sites to improve access for those at higher risk of infection.
10 Feb 2025
New Guidelines Cut Hospital Stays for Febrile Infants
A new clinical practice guideline for well-appearing febrile infants has led to a reduction in hospitalisations, antibiotic use, and invasive procedures.
Loading posts...
1
2
3
…
20
Next »